APIs for research and impurities
Active Pharmaceutical Ingredients (APIs) are the substances in drugs responsible for their therapeutic effects. In this section, you will find a wide variety of APIs intended for research use. These compounds are essential for the development, testing, and validation of new pharmaceutical formulations. CymitQuimica offers high-quality APIs to support research in drug discovery and development.
Subcategories of "APIs for research and impurities"
- Aminoacids and derivatives(12,241 products)
- Anthraquinones and derivatives(401 products)
- Benzimidazole and Imidazole Derivatives(10,345 products)
- Benzodiazepine Derivatives(332 products)
- Carbohydrates and glycoconjugates(5,006 products)
- Esters and Derivatives(42,023 products)
- Fatty Acids and Lypidic Derivatives(32,187 products)
- Flavonoids and Polyphenols(16,990 products)
- Free Radicals and Oxidant/Reducing Agents(213 products)
- Ketones and derivatives(2,393 products)
- Natural and semi-synthetic antibiotics(6,335 products)
- Nitriles and Cyano Derivatives(3,042 products)
- Nitrosamines and Derivatives(55 products)
- Nucleosides and Nucleotides(3,413 products)
- Organic Phosphates and Phosphonates(1,191 products)
- Organic Sulphonates and Sulphates(10,370 products)
- Organometallics(4,396 products)
- Others(6,270 products)
- Peptides and Proteins(3,116 products)
- Polymers and Derivatives(99 products)
- Purines and Pyrimidine Derivatives(8,888 products)
- Quinazoline and Quinoline Derivatives(65,495 products)
- Quinones and Derivatives(24,191 products)
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)(79,238 products)
- Steroids and Derivatives(4,949 products)
- Sulfonamides and Derivatives(2,584 products)
- Terpenoids and Derivatives(3,835 products)
- Thiazolidinediones and Thiopyrans(2,733 products)
- β-Adrenergic Compounds(228 products)
Show 21 more subcategories
Found 56511 products of "APIs for research and impurities"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Empagliflozin impurity 25
CAS:<p>Please enquire for more information about Empagliflozin impurity 25 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C13H9BrClFPurity:Min. 95%Color and Shape:PowderMolecular weight:299.57 g/molEthyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
CAS:<p>Ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate is a synthetic compound that belongs to the class of piperidines. It is a metabolite of ethyl 4-[(8-chloro-2,3,4,7-tetrahydrobenzo[c]chromen-3-ylidene)amino]piperidine-1carboxylate and has been shown to have an antiinflammatory effect in animal models. Ethyl 4-(8-chloro-11H benzo[5,6]cyclohepta[1,2 b]pyridin 11 ylidene) piperidine 1 carboxylate has been used as an analytical standard for HPLC and as an impurity standard for API.</p>Formula:C22H21ClN2O2Purity:Min. 95%Molecular weight:380.9 g/mol2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one)
CAS:<p>Please enquire for more information about 2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C28H16N2O6SPurity:Min. 95%Molecular weight:508.5 g/mol11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine
CAS:<p>11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine is a molecule that inhibits the replication of DNA and RNA in viruses. The structure of 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine has been determined by X-ray crystallography. Hepatocyte cells were used for this study because they are important for the metabolism of drugs. This molecule binds to serine proteases and prevents them from functioning properly. It also inhibits the replication of hepatitis C virus and human immunodeficiency virus type 1 (HIV-1). 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine can be used as a template for designing other molecules with antiviral</p>Formula:C30H24N4S2Purity:Min. 95%Color and Shape:Yellow SolidMolecular weight:504.67 g/mol(S,R)-Cis-clopidogrel-mp derivative
CAS:<p>Please enquire for more information about (S,R)-Cis-clopidogrel-mp derivative including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C25H26ClNO6SPurity:Min. 95%Molecular weight:504 g/molGS 441524 triphosphate
CAS:<p>Triphosphorylated form of an antiviral nucleoside analog with activity against zoonotic feline infectious peritonitis virus (FIPV) and severe acute respiratory syndrome (SARS) virus from Coronaviridae family. The compound is the biologically active form of the GS 441524 prodrug and being triphosphorylated, it competes with natural nucleoside triphosphates in cells and interferes with viral RNA synthesis. Made to order.</p>Formula:C12H12N5O13P3·4NaPurity:(31P-Nmr) Min. 95 Area-%Color and Shape:White PowderMolecular weight:531.20 g/molN1,N2-Bis[2-(diethylamino)ethyl]ethanediamide
CAS:<p>Please enquire for more information about N1,N2-Bis[2-(diethylamino)ethyl]ethanediamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C14H30N4O2Purity:Min. 95%Molecular weight:286.41 g/mol(-)-Sabinene
CAS:<p>(-)-Sabinene is a natural compound found in urine and various medicinal plants, including Chinese herbs. It has been identified as an analog of another natural compound that exhibits potent anticancer activity. (-)-Sabinene has been shown to inhibit the activity of certain proteins involved in cell cycle regulation and apoptosis, which are important processes for the growth and survival of cancer cells. In addition, (-)-Sabinene has been found to have inhibitory effects on tumor kinase activity, making it a promising candidate for the development of new anticancer drugs. Studies have shown that (-)-Sabinene can effectively inhibit the growth of various types of cancer cells, making it a potential therapeutic agent for the treatment of cancer.</p>Formula:C10H16Purity:Min. 95%Color and Shape:Clear LiquidMolecular weight:136.23 g/mol2-(Sulfoacetamido) dimoxystrobin acetic acid
CAS:<p>2-(Sulfoacetamido) dimoxystrobin acetic acid is a compound that has been extensively studied for its various properties. It is known to have a mass spectrum similar to triclosan and has been found to inhibit the production of interleukin-6, a pro-inflammatory cytokine. This compound has also shown promise as a monoclonal antibody and has shown inhibitory effects on the growth of hepatocytes by blocking the action of growth factors. Additionally, it acts as a cdk4/6 inhibitor, which is important in regulating cell cycle progression. The presence of glycine and phycocyanin in this compound suggests potential hydrogen bonding interactions, while the amide group indicates its ability to form stable complexes with other compounds. The racemase activity exhibited by this compound may contribute to its biological activity, while its interaction with β-catenin suggests potential involvement in cellular signaling pathways. Overall, 2-(Sulfoacetamido) dim</p>Formula:C12H15NO6SPurity:Min. 95%Molecular weight:301.32 g/molMethacycline
CAS:<p>Methacycline, a tetracycline antibiotic, inhibits bacterial protein synthesis and effectively suppresses epithelial-mesenchymal transition (EMT). It blocks EMT in vitro and inhibits fibrogenesis in vivo without directly affecting the TGF-β1Smad signaling pathway. As an antimicrobial agent, Methacycline holds potential for research in pulmonary fibrosis.</p>Formula:C22H22N2O8Color and Shape:SolidMolecular weight:442.427-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid
CAS:<p>7-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid is a synthetic drug product with a purity of >98%. It is an impurity standard for HPLC methods. This compound has been studied extensively in metabolism studies and pharmacological assays. 7-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a -phenyl 1a-[(phenylamino)carbonyl]-3H -oxireno[3,4]pyrrolo[2,1 -</p>Formula:C33H35FN2O7Purity:Min. 95%Molecular weight:590.64 g/molDopachrome
CAS:<p>Dopachrome is an analog that has been studied for its potential as an anticancer agent. It works by inhibiting protein kinases, which are enzymes that play a key role in tumor growth and progression. Dopachrome has shown promise as an inhibitor of cancer cell growth in both urine and human cells. In medicinal studies, it has been found to induce apoptosis, or programmed cell death, in Chinese hamster ovary cells. These findings suggest that dopachrome may have therapeutic potential as a cancer treatment. Further research is needed to fully understand the mechanisms of action and potential side effects of this promising compound.</p>Formula:C9H7NO4Purity:Min. 95%Molecular weight:193.16 g/mol7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol
CAS:<p>7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol is a potent inhibitor of polymerase chain reaction (PCR) that is synthesized by a chemical reaction. It inhibits the activity of c-jun phosphorylation and DNA synthesis in HL60 cells. 7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol is also an apoptosis inducer for HL60 cells. This agent has been shown to induce apoptosis by binding to DNA template and inhibiting mitochondrial functions. The mechanism of action for this compound is not fully understood but may involve mitochondrial membrane potential and multivariate logistic regression analysis.</p>Formula:C20H14O3Purity:Min. 95%Molecular weight:302.3 g/mol9,17-Dihydroxycorticosterone 21-acetate
CAS:Controlled Product<p>Please enquire for more information about 9,17-Dihydroxycorticosterone 21-acetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C23H32O7Purity:Min. 95%Molecular weight:420.5 g/molDoxorubicin Dimer Impurity-1
<p>Doxorubicin Dimer Impurity-1 is a drug product that is used as an HPLC standard. It is a metabolite of doxorubicin and has been shown to inhibit DNA synthesis in vitro. This impurity has been detected in the drug product using HPLC, and the purity of this impurity is greater than 98%. Doxorubicin Dimer Impurity-1 is a synthetic compound that has not been found in natural sources. It has been shown to be metabolized by human enzymes, such as esterases, glucuronidases, glutathione reductase, cytochrome P450 enzymes, and glucuronic acid conjugates. Doxorubicin Dimer Impurity-1 may also have anti-inflammatory properties due to its ability to inhibit prostaglandin synthesis.</p>Formula:C54H56N2O21Purity:Min. 95%Molecular weight:1,069.02 g/mol11α-Hydroxyandrosta-1,4-dien-3,17-dione
CAS:Controlled Product<p>11α-Hydroxyandrosta-1,4-dien-3,17-dione is an analog of tolvaptan that acts as a kinase inhibitor. It has been shown to inhibit the growth of cancer cells and tumors in humans by inducing apoptosis through the inhibition of protein kinases. This compound has also been found in Chinese urine and is currently being studied as a potential anticancer drug. Additionally, 11α-Hydroxyandrosta-1,4-dien-3,17-dione has been shown to be effective against a variety of kinase inhibitors, making it a promising candidate for future cancer treatment options.</p>Formula:C19H24O3Purity:Min. 95%Color and Shape:PowderMolecular weight:300.4 g/mol(R,R)-(+)-Homoanatoxin A hydrochloride
CAS:<p>(R,R)-(+)-Homoanatoxin A hydrochloride is a potent inhibitor of protein phosphatases and has been shown to induce apoptosis in human cell lines. It has potential as an anticancer agent due to its ability to inhibit the growth and proliferation of cancer cells by inducing cell cycle arrest and cell death. This compound has been isolated from Chinese medicinal herbs and has shown promising results in inhibiting tumor growth in animal models. Additionally, (R,R)-(+)-Homoanatoxin A hydrochloride can be detected in urine samples of cancer patients, suggesting its potential as a biomarker for cancer diagnosis and monitoring treatment efficacy. Overall, this compound shows great promise as a novel therapeutic agent for the treatment of various types of cancers.</p>Formula:C11H17NO•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:215.72 g/mol1-(4-Fluorophenyl)-4-[(6bS,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-buta none
CAS:<p>Please enquire for more information about 1-(4-Fluorophenyl)-4-[(6bS,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-buta none including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C24H28FN3OMolecular weight:393.5 g/molN-Nitroso Racepinephrine Solution (1 mL ) (N-(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-N-methylnitrous amide)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C9H12N2O4Color and Shape:Colorless LiquidMolecular weight:212.07971N-Nitroso N,N'-Dibenzylethanediamine Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C16H19N3OMolecular weight:269.15281N-Nitroso N-Methyl Valacyclovir Solution (1 mL )
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H21N7O5Molecular weight:367.16042N-Nitroso N-Desmethyl Pheniramine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H17N3OColor and Shape:Colorless LiquidMolecular weight:255.13716N-Nitroso N-Desmethyl Nizatidine Solution (1 mL )
<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formula:C11H18N6O3S2Color and Shape:Colorless LiquidMolecular weight:346.08818N-Nitroso N-Desmethyl Tamoxifen Solution (1 mL )
Compounds with other nitrogen function, nesoiColor and Shape:Colorless LiquidN-Nitroso Desmethyl Rizatriptan Solution (1 mL )
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C14H16N6OColor and Shape:Light Yellow LiquidMolecular weight:284.13856N-Nitroso Desmethyl Escitalopram Solution (1 mL )
<p>Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoi</p>Formula:C19H18FN3O2Molecular weight:339.1383N-Nitroso Desmethyl Dexchlorpheniramine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H16ClN3OMolecular weight:289.09819N-Nitroso Salmeterol Solution (1 mL ) (N-(2-hydroxy-2-(4-hydroxy-3-(hydroxymethyl)phenyl)ethyl)-N-(6-(4-phenylbutoxy)hexyl)nitrous amide)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C25H36N2O5Color and Shape:Colorless LiquidMolecular weight:444.26242N-Nitroso N-Desmethyl Pyrilamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H20N4O2Molecular weight:300.15863N-Nitroso Propafenone Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C21H26N2O4Color and Shape:Colorless LiquidMolecular weight:370.18926N-Nitroso N-Desmethyl Promethazine Solution (1 mL )
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C16H17N3OSMolecular weight:299.10923N-Nitroso Desipramine Solution (1 mL )
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C18H21N3OMolecular weight:295.16846N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide Solution (1 mL ) (N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide)
<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C14H20N4O2Color and Shape:Clear LiquidMolecular weight:276.15863Dioctyl Methylphosphonate
CAS:Containing a phosphorus atom to which one methyl, ethyl, n-propyl or isopropyl group is bonded but no further carbon atoms, non-halFormula:C17H37O3PMolecular weight:320.24803N-Nitroso Labetalol Solution (1 mL ) (2-hydroxy-5-(1-hydroxy-2-(nitroso(4-phenylbutan-2-yl)amino)ethyl) benzamide)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C19H23N3O4Color and Shape:Colorless LiquidMolecular weight:357.16886N-Nitroso-1,2,3,6-tetrahydropyridine (NTHP) Solution (1 mL ) (1-nitroso-1,2,3,6-tetrahydropyridine)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C5H8N2OColor and Shape:Colorless LiquidMolecular weight:112.06366N-Nitroso-N-methyl-2-phenylethylamine (NMPEA) Solution (1 mL ) (N-methyl-N-phenethylnitrous amide)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C9H12N2OColor and Shape:Colorless LiquidMolecular weight:164.09496N-Nitrosopiperidine Solution (1 mL ) (1-Nitrosopiperidine)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C5H10N2OColor and Shape:Colorless LiquidMolecular weight:114.07931N-Nitroso Nortriptyline Solution (1 mL ) (N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-methylnitrous amide)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C19H20N2OColor and Shape:Colorless LiquidMolecular weight:292.15756N-Nitroso Desmethyl (E)-Doxepin Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C18H18N2O2Molecular weight:294.13683N-Nitroso Epinephrine Solution (1 mL ) ((R)-N-(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-N-methylnitrous amide)
<p>Compounds with other nitrogen function, nesoi</p>Formula:C9H12N2O4Color and Shape:Colorless LiquidMolecular weight:212.079712-(4-Nitrosopiperazin-1-yl)pyrimidine Solution (1 mL ) (2-(4-nitrosopiperazin-1-yl)pyrimidine)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C8H11N5OColor and Shape:LiquidMolecular weight:193.096362-[2-(4-Nitroso-1-piperazinyl)ethoxy]ethanol Solution (1 mL )
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C8H17N3O3Color and Shape:Light Brown LiquidMolecular weight:203.126991-Methyl-4-nitrosopiperazine (MNP) Solution (1 mL ) (1-Methyl-4-nitrosopiperazine)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C5H11N3OColor and Shape:Colorless LiquidMolecular weight:129.09021Diisobutyl Carbonate
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormula:C9H18O3Molecular weight:174.12559Deutero N-Nitrosodimethylamine (NDMA-d6) (1 mL ) (N-(Methyl-d3)-N-nitrosomethan-d3-amine)
CAS:<p>Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoi</p>Formula:C2D6N2OColor and Shape:Yellow LiquidMolecular weight:80.08567N-Nitroso Ramipril Solution (1 mL )
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C23H31N3O6Color and Shape:Colorless LiquidMolecular weight:445.22129N-Nitrosopyrrolidine (NPYR) Solution (1 mL (1-Nitrosopyrrolidine))
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C4H8N2OColor and Shape:Colorless LiquidMolecular weight:100.06366Dodecylcyclohexane
CAS:<p>Cyclanes, cyclenes and cycloterpenes, excluding cyclohexane</p>Formula:C18H36Color and Shape:Colorless LiquidMolecular weight:252.2817N-Nitroso Lapatinib Solution (1 mL )
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C29H25ClFN5O5SMolecular weight:609.1249N-Nitroso Tamsulosin Solution (1 mL ) ((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)(nitroso)amino)propyl)-2-methoxybenzenesulfonamide)
CAS:<p>Sulfonamides, nesoi</p>Formula:C20H27N3O6SColor and Shape:Colorless LiquidMolecular weight:437.16206N-Nitroso Duloxetine Solution (1 mL ) (N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)-N-nitrosopropan-1-amine)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C18H18N2O2SColor and Shape:Colorless LiquidMolecular weight:326.1089Deutero N-Nitrosomethylaminobutyric Acid (NMBA-d3) Solution (1 mL )
CAS:Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoiFormula:C5H7D3N2O3Color and Shape:Colorless LiquidMolecular weight:149.08797N-Nitrosodipropylamine (NDPA) Solution (1 mL ) (N,N-dipropylnitrous amide)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C6H14N2OColor and Shape:Colorless LiquidMolecular weight:130.11061N-Nitroso N-Ethyl Valacyclovir Solution (1 mL )
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C15H23N7O5Molecular weight:381.17607Hexadecane
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C16H34Molecular weight:226.26605Octadecamethylcyclononasiloxane
CAS:Organo-inorganic compounds, nesoiFormula:C18H54O9Si9Molecular weight:666.169124-Nitrosopiperazine-1-ethanol Solution (1 mL ) (2-(4-Nitrosopiperazin-1-yl)ethan-1-ol)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C6H13N3O2Color and Shape:Colorless LiquidMolecular weight:159.10078Cinnamic Acid E/Z
CAS:<p>Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoi</p>Formula:C9H8O2Color and Shape:White PowderMolecular weight:148.05243N-Nitrosodiethylamine (NDEA) (1 mL ) (N-Ethyl-N-nitrosoethanamine)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C4H10N2OColor and Shape:LiquidMolecular weight:102.07931N-Nitroso Sitagliptin Amine (NTTP) Solution (1 mL ) (7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C6H6F3N5OColor and Shape:Colorless LiquidMolecular weight:221.05244N-Nitrosoiminodiacetic acid Solution (1 mL ) (2,2'-(nitrosoazanediyl)diacetic acid)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C4H6N2O5Color and Shape:Colorless LiquidMolecular weight:162.02767Eicosyl Ferulate
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C30H50O4Molecular weight:474.370912-Methyloctacosane
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C29H60Molecular weight:408.4695(11Z)-11-Eicosenamide
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C20H39NOMolecular weight:309.30316N-Nitroso Dipivefrin Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C19H28N2O6Molecular weight:380.194742-Benzyl-2-(dimethylamino)-1-[4-(morpholin-4-yl)phenyl]butan-1-one (2-Benzyl-2-(dimethylamino)-1-(4-morpholinophenyl)butan-1-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H30N2O2Color and Shape:White Crystalline PowderMolecular weight:366.23073N-Nitroso Deschloro Carbinoxamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H17N3O2Molecular weight:271.13208N-Nitroso Trimetazidine Solution (1 mL )
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H21N3O4Molecular weight:295.15321N-Nitroso Brinzolamide Solution (1 mL )
Sulfonamides, nesoiFormula:C12H20N4O6S3Molecular weight:412.0545N-Nitroso Acebutolol Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C18H27N3O5Color and Shape:Colorless LiquidMolecular weight:365.19507N-Nitroso Desmethyl Citalopram Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H18FN3O2Molecular weight:339.1383N-Nitroso Desmethyl Chlorpromazine Solution (1 mL )
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C16H16ClN3OSMolecular weight:333.07026Nitrophenylchlorothiophene Carboxylate (4-nitrophenyl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H6ClNO4SColor and Shape:White Off-White SolidMolecular weight:283.68N-Nitroso Vilanterol Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C24H32Cl2N2O6Molecular weight:514.16374N-Nitroso N-Desmethyl Doxylamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H19N3O2Molecular weight:285.14773N-Nitroso N-Desmethyl Methylene Blue Solution (1 mL )
Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C15H15ClN4OSMolecular weight:334.06551Ethylene Sebacate
CAS:Azelaic acid, sebacic acid, their salts and estersFormula:C12H20O4Molecular weight:228.13616N-Nitroso Hydrochlorothiazide Solution (1 mL )
CAS:Sulfonamides, nesoiFormula:C7H7ClN4O5S2Molecular weight:325.95464N-Nitroso Desmethyl Carbinoxamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiN-Nitroso Fenfluramine Solution (1 mL )
CAS:Compounds with other nitrogen function, nesoiFormula:C12H15F3N2OMolecular weight:260.11365N-Nitroso N-Desmethyl Terbinafine Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C20H22N2OMolecular weight:306.17321N-Nitroso Lorcaserin Solution (1 mL )
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formula:C11H13ClN2OMolecular weight:224.071644-Methyloctane
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C9H20Molecular weight:128.1565Butylphenyl Methylpropional
CAS:Cyclic aldehydes without other oxygen function, odoriferous or flavoring compoundsFormula:C14H20OMolecular weight:204.15142N,N'-Dinitrosopiperazine Solution (1 mL )
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C4H8N4O2Molecular weight:144.06473N-Nitroso N-Desmethyl Ranitidine Solution (1 mL )
Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C12H19N5O4SMolecular weight:329.11578N-Nitroso Ambroxol Solution (1 mL ) (N-(2-amino-3,5-dibromobenzyl)-N-((1r,4r)-4-hydroxycyclohexyl)nitrous amide)
CAS:<p>Compounds with other nitrogen function, nesoi</p>Formula:C13H17Br2N3O2Color and Shape:Yellow LiquidMolecular weight:404.968752-Methyl-4'-(methylthio)-2-morpholinopropiophenone
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H21NO2SColor and Shape:White PowderMolecular weight:279.1293N-Nitroso N-Desmethyl Rivastigmine Solution (1 mL )
CAS:Compounds with other nitrogen function, nesoiFormula:C13H19N3O3Molecular weight:265.14264N-Nitroso N-Desmethyl Venlafaxine Solution (1 mL ) (N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylnitrous amide)
CAS:Compounds with other nitrogen function, nesoiFormula:C16H24N2O3Molecular weight:292.178692-Phenylphenol ([1,1'-Biphenyl]-2-ol)
CAS:Monophenols, nesoiFormula:C12H10OColor and Shape:White SolidMolecular weight:170.07316N-Nitroso Desmethyl Cidoxepin Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C18H18N2O2Molecular weight:294.13683Monobutyl Phthalate (2-(Butoxycarbonyl)benzoic acid)
CAS:Formula:C12H14O4Color and Shape:White PowderMolecular weight:222.089214,6-Dimethyldodecane
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFormula:C14H30Molecular weight:198.23475Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-
CAS:Formula:C24H23ClO2Purity:98%Color and Shape:SolidMolecular weight:378.8912S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
CAS:Formula:C19H18F3N3O6Purity:98%Color and Shape:SolidMolecular weight:441.3579Ref: IN-DA00C6E9
Discontinued product




